CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
CureVac Total Assets (Quarterly) : 1.338B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 1.338B |
| June 30, 2025 | 808.64M |
| March 31, 2025 | 801.80M |
| December 31, 2024 | 831.33M |
| September 30, 2024 | 953.32M |
| June 30, 2024 | 596.79M |
| March 31, 2024 | 745.67M |
| December 31, 2023 | 870.74M |
| September 30, 2023 | 892.07M |
| June 30, 2023 | 981.33M |
| March 31, 2023 | 1.058B |
| December 31, 2022 | 918.34M |
| Date | Value |
|---|---|
| September 30, 2022 | 891.98M |
| June 30, 2022 | 967.90M |
| March 31, 2022 | 1.142B |
| December 31, 2021 | 1.317B |
| September 30, 2021 | 1.927B |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 1.849B |
| September 30, 2020 | 1.198B |
| June 30, 2020 | |
| March 31, 2020 | 170.79M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| PAION AG | -- |
| Anbio Biotechnology | -- |
| Epigenomics AG | -- |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alkermes Plc | 4.393B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 314.18M |
| Shareholders Equity (Quarterly) | 1.024B |